US FDA to subject blood-thinning drug to genetic test
In the first move of its kind, the US Food and Drug Administration (FDA) - the agency responsible for regulating food, drugs and biological medical products - has recommended a genetic test prior to the prescription of a drug, Warfarin, in order to gauge potential patient response. Warfarin, sold...